Application 208083
- Type
- NDA
- Sponsor
- BAXTER HLTHCARE CORP
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | SOLUTION;INTRAVENOUS | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | Yes | Yes |
| 002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | SOLUTION;INTRAVENOUS | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | Yes | Yes |
| 003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | SOLUTION;INTRAVENOUS | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | |
| N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | |
| N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | CLINDAMYCIN PHOSPHATE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2020-12-22 03:56 UTC | 2020-12 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N208083-001 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 300MG BASE/50ML (EQ 6MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N208083-002 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 600MG BASE/50ML (EQ 12MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N208083-003 | CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE | EQ 900MG BASE/50ML (EQ 18MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2017-04-20 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Baxter Healthcare Company | 44fa506b-90ac-42de-831b-5f3f1a500fc0 | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 208083 NDA208083 0338-9553 0338-9545 0338-9549 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9545 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9549 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
| 0338-9553 | clindamycin phosphate | clindamycin phosphate | Baxter Healthcare Corporation | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 72006 | SUPPL | 2022-09-02 |
| 72005 | SUPPL | 2022-09-02 |
| 72004 | SUPPL | 2022-09-02 |
| 71999 | SUPPL | 2022-09-02 |
| 71998 | SUPPL | 2022-09-02 |
| 71997 | SUPPL | 2022-09-02 |
| 66308 | SUPPL | 2021-02-22 |
| 66300 | SUPPL | 2021-02-19 |
| 59567 | SUPPL | 2019-08-02 |
| 59552 | SUPPL | 2019-08-02 |
| 48821 | ORIG | 2017-06-26 |
| 48080 | ORIG | 2017-04-21 |
| 48072 | ORIG | 2017-04-21 |